The QUANTI OBR Phase 3 trial investigating gadoquatrane for contrast-enhanced MRI of the body with up to 60% less gadolinium - Palkowitsch, Petra; Fursenko, Viktoriia; Liu, Alex; Hofmann, Birte; Klemens, Mark (Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition, 2026)
Program Number: 567-06-003